Characterization of Orthobiologic Agents Used for Point of Care Ultrasound Guided Procedures and Associated Outcomes

Overview

About this study

The purpose of this study is to determine patient and manufacturing factors that influence orthobiologic agent (OBA) product components and determine how they may influence patient outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patient, age ≥ 18 years old.
Any adult patient who undergoes OBA procedure Mayo Clinic Regenerative Medicine practice.

Exclusion Criteria:

Age < 18 years years old.
Unable or unwilling to complete electronic patient reported outcome tools (e.g., no email address).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Jacob Sellon, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Candee Mills L.A.T., A.T.C. (507) 266-6690 Mills.Candee@mayo.edu
Minneapolis, Minn. Mayo Clinic principal investigator Jonathan Finnoff, D.O.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Candee Mills L.A.T., A.T.C. (507) 266-6690 Mills.Candee@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Shane Shapiro, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Karina Gonzalez Carta M.S. (507) 293-1762 Carta.Karina@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Sellon, M.D.

Closed-enrolling by invitation

Contact information:

Candee Mills L.A.T., A.T.C.

(507) 266-6690

Mills.Candee@mayo.edu

Minneapolis, Minn.

Mayo Clinic principal investigator

Jonathan Finnoff, D.O.

Closed-enrolling by invitation

Contact information:

Candee Mills L.A.T., A.T.C.

(507) 266-6690

Mills.Candee@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Shane Shapiro, M.D.

Closed-enrolling by invitation

Contact information:

Karina Gonzalez Carta M.S.

(507) 293-1762

Carta.Karina@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials